高级检索
当前位置: 首页 > 详情页

Macrophage migration inhibitory factor contributes to the pathogenesis of benign lymphoepithelial lesion of the lacrimal gland

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]College of Life Science and Bio-engineering, Beijing Molecular HydrogenResearch Center, Beijing University of Technology, Beijing 100124, People’sRepublic of China [2]Beijing Tongren Hospital, Capital Medical University,Beijing 100730, People’s Republic of China [3]Beijing Ophthalmology & VisionScience Key Lab, Beijing Tongren Eye Center, Beijing 100730, People’sRepublic of China [4]Department of Plastic Surgery, Peking Union MedicalCollege Hospital, Beijing 100730, People’s Republic of China [5]Beijing DitanHospital, Capital Medical University, Beijing 100015, People’s Republic ofChina
出处:
ISSN:

关键词: Benign Lymphoepithelial lesion Macrophage migration inhibitory factor Pathogenesis Inflammation Fibrosis

摘要:
BackgroundBenign Lymphoepithelial Lesion (BLEL) is a rare disease observed in the adult population. Despite the growing numbers of people suffering from BLEL, the etiology and mechanisms underlying its pathogenesis remain unknown.MethodsIn the present study, we used gene and cytokines expression profiling, western blot and immunohistochemistry to get further insight into the cellular and molecular mechanisms involved in the pathogenesis of BLEL of the lacrimal gland.ResultsThe results showed that Macrophage Migration Inhibitory Factor (MIF) was the most highly expressed cytokine in BLEL, and its expression positively correlated with the expression of Th2 and Th17 cells cytokines. MIF was found to regulate biological functions and pathways involved in BLEL pathogenesis, such as proliferation, resistance to apoptosis, MAPK and PI3K/Akt pathways. We also found that MIF promotes fibrosis in BLEL by inducing BLEL fibroblast differentiation into myofibroblasts as well as the synthesis and the deposit of extracellular matrix in BLEL tissues.ConclusionsOur findings demonstrate the contribution of MIF to the pathogenesis of BLEL of the lacrimal gland and suggested MIF as a promising therapeutic target for its treatment.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 2 区 生物
小类 | 3 区 细胞生物学
最新[2023]版:
大类 | 2 区 生物学
小类 | 2 区 细胞生物学
JCR分区:
出版当年[2016]版:
Q2 CELL BIOLOGY
最新[2023]版:
Q1 CELL BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]College of Life Science and Bio-engineering, Beijing Molecular HydrogenResearch Center, Beijing University of Technology, Beijing 100124, People’sRepublic of China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21169 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)